top of page

Eyes on Pharma
Check-out What Intel Caught our Eye

Jana Chisholm
Jan 206 min read
BioPharma M&A Update
According to an annual PwC study released in December, the amount of M&A activity in the pharmaceutical and life sciences sectors in 2024...


Jana Chisholm
Nov 17, 20244 min read
Eyes on Sanofi, Regeneron, Novo Nordisk, and Pfizer
We've had Eyes On some of the recent deals, results, and investor actions. Check out the happenings at Sanofi/Opella, Pfizer, Regeneron, and

Jana Chisholm
Jul 7, 20245 min read
Eyes on Oncology, Anti-Virals, and Consumer Products
We've had our Eyes On recent data releases, commercial strategy updates, and some FDA updates. What caught your Eye last week?

Jana Chisholm
May 18, 20245 min read
Eyes on Pharma Restructures + Pfizer's Clinical SAE
We've had Eyes On recent news further clarifying company restructures. In the midst of refining pipelines, and cutting corporate spending ..


Jana Chisholm
Dec 1, 20233 min read
Eyes on Clinical Trial Data, Supply Upgrades, and Patent Litigation
The news this week was full of "Ups-n-Downs." We've noted a few here and know there were more surprises with clinical data results, M&A, and
bottom of page